At present, a large number of studies have shown that PIM-3 is mainly over-expressed in solid tumors, such as lung cancer, gastric cancer, pancreatic cancer, colorectal cancer, liver cancer, and prostate cancer. This evidence concerns the gene PIM3 and lung carcinoma.